Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Welltower (NYSE:WELL) Stock Price Target Lowered at Cantor Fitzgerald

Welltower logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Cantor Fitzgerald lowered Welltower’s price target from $260 to $258 while maintaining an “overweight” rating, implying approximately 13.66% upside from the current share price.
  • Analyst sentiment remains broadly positive: Welltower has a “Moderate Buy” consensus rating and an average target price of $258.48, despite mixed revisions from firms including Barclays and Weiss Ratings.
  • Welltower’s latest quarterly results exceeded expectations, with EPS of $1.67 versus the $1.64 consensus and revenue of $3.72 billion, up 38.4% year over year.
  • Five stocks to consider instead of Welltower.

Welltower (NYSE:WELL - Get Free Report) had its price objective cut by stock analysts at Cantor Fitzgerald from $260.00 to $258.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an "overweight" rating on the real estate investment trust's stock. Cantor Fitzgerald's target price indicates a potential upside of 13.66% from the stock's current price.

Several other analysts have also recently issued reports on the stock. Citigroup increased their target price on shares of Welltower from $255.00 to $275.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Weiss Ratings cut shares of Welltower from a "buy (b-)" rating to a "hold (c)" rating in a report on Wednesday. Barclays dropped their price objective on Welltower from $259.00 to $246.00 and set an "equal weight" rating for the company in a research note on Tuesday, October 13th. Royal Bank Of Canada boosted their target price on Welltower from $238.00 to $260.00 and gave the stock an "outperform" rating in a research report on Monday, August 3rd. Finally, Wells Fargo & Company raised their price target on Welltower from $266.00 to $268.00 and gave the company an "overweight" rating in a report on Monday, October 19th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Welltower has a consensus rating of "Moderate Buy" and a consensus target price of $258.48.

Read Our Latest Stock Analysis on Welltower

Welltower Stock Up 0.1%

Welltower stock opened at $226.99 on Thursday. The firm has a 50 day simple moving average of $233.63 and a 200 day simple moving average of $217.77. The firm has a market capitalization of $163.60 billion, a price-to-earnings ratio of 98.26, a P/E/G ratio of 1.15 and a beta of 0.75. The company has a current ratio of 3.16, a quick ratio of 3.16 and a debt-to-equity ratio of 0.37. Welltower has a 1-year low of $174.91 and a 1-year high of $255.20.

Welltower (NYSE:WELL - Get Free Report) last announced its quarterly earnings results on Monday, October 26th. The real estate investment trust reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.03. Welltower had a net margin of 12.15% and a return on equity of 3.56%. The firm had revenue of $3.72 billion for the quarter, compared to the consensus estimate of $3.64 billion. During the same period in the prior year, the firm posted $1.34 earnings per share. The company's revenue for the quarter was up 38.4% on a year-over-year basis. On average, analysts predict that Welltower will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other Welltower news, Director Andrew Gundlach purchased 5,000 shares of the firm's stock in a transaction on Wednesday, August 26th. The shares were purchased at an average cost of $242.06 per share, with a total value of $1,210,300.00. Following the completion of the purchase, the director owned 30,000 shares of the company's stock, valued at $7,261,800. The trade was a 20.00% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is owned by insiders.

Institutional Investors Weigh In On Welltower

A number of institutional investors have recently made changes to their positions in WELL. Leonteq Securities AG grew its stake in shares of Welltower by 92.3% during the 1st quarter. Leonteq Securities AG now owns 125 shares of the real estate investment trust's stock worth $25,000 after purchasing an additional 60 shares during the period. Kilter Group LLC acquired a new position in shares of Welltower in the 2nd quarter valued at $29,000. Sound Income Strategies LLC lifted its stake in shares of Welltower by 124.6% in the 1st quarter. Sound Income Strategies LLC now owns 137 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 76 shares during the period. Solstein Capital LLC purchased a new stake in Welltower during the second quarter worth $34,000. Finally, Summit Securities Group LLC boosted its holdings in Welltower by 42.6% during the second quarter. Summit Securities Group LLC now owns 164 shares of the real estate investment trust's stock worth $37,000 after buying an additional 49 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company's stock.

Welltower News Roundup

Here are the key news stories impacting Welltower this week:

  • Positive Sentiment: Welltower reported strong senior-housing performance, including 24.6% year-over-year normalized FFO growth, 15.8% same-store NOI growth and a 9.1% increase in same-store senior housing operating revenue. Higher occupancy, expanding margins and acquisitions helped drive results. Welltower upgraded after Q3 results
  • Positive Sentiment: Management raised its full-year FFO outlook, supported by continued portfolio growth and resilient demand for senior housing properties. Several reports characterized the quarter as an FFO beat. WELL Q3 FFO beat estimates
  • Positive Sentiment: Freedom Broker upgraded WELL from “hold” to “buy” and assigned a $255 price target, signaling confidence that the company’s growth and investment-grade balance sheet can support further gains. Freedom Broker upgrade
  • Neutral Sentiment: Welltower’s $21 billion acquisition and investment activity is expanding its senior-housing platform, but investors are assessing whether the growth sufficiently justifies the company’s premium valuation.
  • Negative Sentiment: Revenue and reported earnings fell short of some estimates, overshadowing the FFO beat and raised guidance. This results-related disappointment triggered selling. Welltower shares down after earnings miss
  • Negative Sentiment: Analysts and investors are concerned that Welltower’s high price-to-earnings valuation, rising leverage and exposure to higher interest rates leave limited room for execution setbacks. Why Welltower sold off despite strong earnings
  • Negative Sentiment: Recent prospectus supplements covering potential common-share issuances may raise dilution concerns, although the filings do not necessarily mean shares will be issued immediately.

Welltower Company Profile

(Get Free Report)

Welltower Inc NYSE: WELL is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company's senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.

See Also

Analyst Recommendations for Welltower (NYSE:WELL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Welltower Right Now?

Before you consider Welltower, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.

While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines